Legend Biotech Corp to Discuss the Management Transition Business Update Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Legend Biotech Business Update Meeting. (Operator Instructions). Please be advised that today's conference is being recorded. I'd now like to hand the conference over to your first speaker today, Jessie Yeung. Thank you. Please go ahead.
Thank you, [Fenning]. This is Jessie Yeung, Head of Corporate Finance and Investor Relations at Legend Biotech. Thanks for dialing into the call and webcast on [shot motives]. With me today, we have Dr. Frank Zhang, Chairman and CEO of Legend; Philip Yau, Chairman of the Committee; and Ying Huang, our CFO.
On today's call, we will be making statements about future expectations, plans, and prospects as well as any other statements regarding matters that are not historical facts [that may concert to your] forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These statements include but are not limited to: statements relating to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
